A carregar...
SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Most tumors initially respond to cytotoxic treatments, but acquired resistance often follows. The tumor microenvironment (TME) is a major barrier to clinical success by compromising therapeutic efficacy, and pathological relevance of multiple soluble factors released by a therapeutically remodeled T...
Na minha lista:
| Publicado no: | Oncogene |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4994019/ https://ncbi.nlm.nih.gov/pubmed/26751775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.494 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|